Other Events ·
GSK plc announced plans to establish a new flagship R&D centre on the Cambridge Biomedical Campus in the UK, investing…
GSKGSK plc
GSK plc announced plans to establish a new flagship R&D centre on the Cambridge Biomedical Campus in the UK, investing £400 million over three years. The 300,000 square foot facility will house more than 1,000 scientists and support research in Oncology, Respiratory, Hepatology, Vaccines, and HIV. The move involves vacating the Stevenage site by 2029 and upgrading laboratories in Ware to integrate drug development and commercial manufacturing. This investment aims to accelerate the R&D pipeline by leveraging the local biomedical ecosystem. GSK is a global biopharma company focused on vaccines, specialty medicines, and consumer healthcare.